Emyria to Develop Novel Psychedelics Pipeline with UWA
Filed with ASX · · 5 pages · English
● Emyria has secured exclusive rights to a library of more than 100 novel MDMA analogues from the University of Western Australia creating a unique drug-discovery pipeline ● The library of compounds has been developed by the highly regarded research group of medicinal chemist, Dr. Matt Piggott, who has been working with MDMA analogues, and exploring their therapeutic potential, for more than 10 ye
Earlier from Emyria
- Emyria Advances EMD-004 Program Towards Registration
- Emyria Data Validated, Care Model Reduces Opioids
- Emyria Obtains TGA Approval for Medical Grade Monitoring App
- Emyria and MMA launch MDMA-assisted therapy program for PTSD
- $5m Placement for Drug Registration and Treatment Pipeline
Later from Emyria
- Emyria Executes Pure CBD Agreement with AltaSciences
- Emyria Appoints Expert Neuropharmacologist for MDMA Program
- Emyria Engages Calvert Labs for Preclinical CBD studies
- MDMA-analogues Show Promise for Parkinsons Disease
- Emyria Expands Psychiatry Advisory for Psychedelics and MDMA
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria